Samuel C. Blackman - HEAD OF R&D at Day One Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Head Of R&D
Issuer Symbol
DAWN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Samuel C. Blackman since 06 Mar 2025

Holdings reported by Samuel C. Blackman for Day One Biopharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,034,015 $13,764,084 $13.31 10 Dec 2024 Direct
Common Stock 1,000,000 $13,311,300 $13.31 10 Dec 2024 Indirect
Restricted Stock Unit (RSU) 84,876 $1,364,696 $16.08 15 May 2024 Direct Common Stock
Restricted Stock Unit (RSU) 72,752 $961,068 $13.21 15 Nov 2024 Direct Common Stock
Stock Option (right to buy Common Stock) 148,000 05 Jan 2024 Direct Common Stock

Transactions reported by Samuel C. Blackman for Day One Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.